About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...
Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, ...
WASHINGTON, D.C. – Whether insurers cover weight loss drugs like Ozempic is a unique risk proposition that needs more data. According to research earlier this year from Morningstar DBRS, health and ...
Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...